Each company must decide if it wants to use the current legislation. It's clear that, in Canada, the legislation is complex. Other companies know what happened in the Apotex case and, for now, they have decided that it's not worth their while to try to use the legislation.
As I said, our companies already export generic medicines to developing countries, but it is currently too difficult to try to use this legislation and to obtain a licence authorizing the export of patented medicines.